| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | transmembrane signaling receptor activity | GABRP OR5AK2 HLA-DQB1 HLA-DQB2 CCR9 GPR52 TLR6 IL18RAP OR1L3 FZD4 OR10G6 GPR83 UNC5A OR8G5 OR5L2 NPBWR1 OR5V1 LPAR5 P2RY12 GPR35 ADGRL1 OR5AK3P OR8U3 OR8J1 ACKR4 GRM5 EDNRB OPRM1 IFNAR1 OR8G1 OR2C1 IFNGR1 OR12D3 P2RY6 CXCR6 OR51M1 TLR1 FZD10 OR4C13 MUSK HCRTR2 | 1.37e-10 | 1353 | 200 | 41 | GO:0004888 |
| GeneOntologyMolecularFunction | G protein-coupled receptor activity | OR5AK2 CCR9 GPR52 OR1L3 FZD4 OR10G6 GPR83 OR8G5 OR5L2 NPBWR1 OR5V1 LPAR5 P2RY12 GPR35 ADGRL1 OR5AK3P OR8U3 OR8J1 ACKR4 GRM5 EDNRB OPRM1 OR8G1 OR2C1 OR12D3 P2RY6 CXCR6 OR51M1 FZD10 OR4C13 HCRTR2 | 1.13e-09 | 884 | 200 | 31 | GO:0004930 |
| GeneOntologyMolecularFunction | odorant binding | 5.42e-06 | 127 | 200 | 9 | GO:0005549 | |
| GeneOntologyMolecularFunction | cytokine receptor activity | 5.94e-06 | 97 | 200 | 8 | GO:0004896 | |
| GeneOntologyMolecularFunction | immune receptor activity | HLA-DQB1 HLA-DQB2 CCR9 IL18RAP FZD4 GPR35 ACKR4 IFNAR1 IFNGR1 CXCR6 | 6.60e-06 | 165 | 200 | 10 | GO:0140375 |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase activator activity | 1.62e-05 | 16 | 200 | 4 | GO:0061575 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | ABCA2 BRIP1 ABCA13 NAIP WRNIP1 ATP9B RECQL5 DNAH9 RFC5 ATP8B2 ABCA5 ATP12A POLQ DHX34 TDRD12 | 4.05e-05 | 441 | 200 | 15 | GO:0016887 |
| GeneOntologyMolecularFunction | ATP-dependent activity | ABCA2 BRIP1 ABCA13 NAIP WRNIP1 ATP9B DNAH14 ACSM3 RECQL5 DNAH9 ZNFX1 RFC5 ATP8B2 ABCA5 ATP12A POLQ DHX34 TDRD12 | 4.85e-05 | 614 | 200 | 18 | GO:0140657 |
| GeneOntologyMolecularFunction | hexosyltransferase activity | 5.51e-05 | 211 | 200 | 10 | GO:0016758 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC17A2 SLC29A3 ABCA2 ABCA13 SLCO1B3 MFSD4B SLC13A4 SLC16A9 SLC6A13 ABCA5 SLC15A2 SLC18A2 SLC25A1 SLC17A8 ATP12A | 9.76e-05 | 477 | 200 | 15 | GO:0022804 |
| GeneOntologyMolecularFunction | olfactory receptor activity | OR5AK2 OR1L3 OR10G6 OR8G5 OR5L2 OR5V1 OR5AK3P OR8U3 OR8J1 OR8G1 OR2C1 OR12D3 OR51M1 OR4C13 | 1.19e-04 | 431 | 200 | 14 | GO:0004984 |
| GeneOntologyMolecularFunction | G protein-coupled chemoattractant receptor activity | 1.23e-04 | 26 | 200 | 4 | GO:0001637 | |
| GeneOntologyMolecularFunction | chemokine receptor activity | 1.23e-04 | 26 | 200 | 4 | GO:0004950 | |
| GeneOntologyMolecularFunction | symporter activity | SLC17A2 MFSD4B SLC13A4 SLC16A9 SLC6A13 SLC15A2 SLC18A2 SLC17A8 | 1.38e-04 | 150 | 200 | 8 | GO:0015293 |
| GeneOntologyMolecularFunction | UDP-glycosyltransferase activity | 1.58e-04 | 153 | 200 | 8 | GO:0008194 | |
| GeneOntologyMolecularFunction | helicase activity | 1.97e-04 | 158 | 200 | 8 | GO:0004386 | |
| GeneOntologyMolecularFunction | N-acetyllactosaminide beta-1,6-N-acetylglucosaminyltransferase activity | 2.97e-04 | 3 | 200 | 2 | GO:0008109 | |
| GeneOntologyMolecularFunction | ribonucleoside binding | 2.97e-04 | 3 | 200 | 2 | GO:0032549 | |
| GeneOntologyMolecularFunction | G protein-coupled ADP receptor activity | 2.97e-04 | 3 | 200 | 2 | GO:0001621 | |
| GeneOntologyMolecularFunction | DNA helicase activity | 3.90e-04 | 62 | 200 | 5 | GO:0003678 | |
| GeneOntologyMolecularFunction | glucuronosyltransferase activity | 4.01e-04 | 35 | 200 | 4 | GO:0015020 | |
| GeneOntologyMolecularFunction | NAD+ nucleotidase, cyclic ADP-ribose generating | 5.03e-04 | 16 | 200 | 3 | GO:0061809 | |
| GeneOntologyMolecularFunction | transporter activity | SLC17A2 GABRP SLC29A3 ABCA2 ABCA13 PKD1L1 SLCO1B3 ATP9B MFSD4B RYR1 SLC13A4 SLC22A14 KCNK1 CACNA1B CACNA1E AQP10 SLC16A9 ATP8B2 OPRM1 SLC6A13 ABCA5 SLC15A2 SLC18A2 SLC25A1 SLC17A8 ATP12A | 5.17e-04 | 1289 | 200 | 26 | GO:0005215 |
| GeneOntologyMolecularFunction | creatine transmembrane transporter activity | 5.91e-04 | 4 | 200 | 2 | GO:0005308 | |
| GeneOntologyMolecularFunction | Toll-like receptor 2 binding | 5.91e-04 | 4 | 200 | 2 | GO:0035663 | |
| GeneOntologyMolecularFunction | glycosyltransferase activity | 6.76e-04 | 288 | 200 | 10 | GO:0016757 | |
| GeneOntologyMolecularFunction | toxic substance binding | 7.23e-04 | 18 | 200 | 3 | GO:0015643 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC17A2 GABRP SLC29A3 ABCA2 ABCA13 PKD1L1 SLCO1B3 MFSD4B RYR1 SLC13A4 SLC22A14 KCNK1 CACNA1B CACNA1E AQP10 SLC16A9 OPRM1 SLC6A13 ABCA5 SLC15A2 SLC18A2 SLC25A1 SLC17A8 ATP12A | 7.65e-04 | 1180 | 200 | 24 | GO:0022857 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC17A2 SLCO1B3 MFSD4B SLC13A4 SLC16A9 SLC6A13 SLC15A2 SLC18A2 SLC25A1 SLC17A8 | 8.34e-04 | 296 | 200 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | FAD binding | 9.69e-04 | 44 | 200 | 4 | GO:0071949 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase (NADPH) activity | 9.79e-04 | 5 | 200 | 2 | GO:0052851 | |
| GeneOntologyMolecularFunction | ferric-chelate reductase activity | 9.79e-04 | 5 | 200 | 2 | GO:0000293 | |
| GeneOntologyMolecularFunction | cupric reductase (NADH) activity | 9.79e-04 | 5 | 200 | 2 | GO:0008823 | |
| GeneOntologyMolecularFunction | interferon receptor activity | 9.79e-04 | 5 | 200 | 2 | GO:0004904 | |
| GeneOntologyMolecularFunction | DNA/RNA hybrid binding | 9.79e-04 | 5 | 200 | 2 | GO:0071667 | |
| GeneOntologyMolecularFunction | protein serine/threonine kinase activator activity | 1.12e-03 | 78 | 200 | 5 | GO:0043539 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 1.15e-03 | 46 | 200 | 4 | GO:0005245 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 1.27e-03 | 119 | 200 | 6 | GO:0015294 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.33e-03 | 81 | 200 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | C-C chemokine receptor activity | 1.51e-03 | 23 | 200 | 3 | GO:0016493 | |
| GeneOntologyMolecularFunction | single-stranded DNA helicase activity | 1.51e-03 | 23 | 200 | 3 | GO:0017116 | |
| GeneOntologyMolecularFunction | cyclin-dependent protein serine/threonine kinase regulator activity | 1.69e-03 | 51 | 200 | 4 | GO:0016538 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | 1.71e-03 | 171 | 200 | 7 | GO:0015081 | |
| GeneOntologyMolecularFunction | C-C chemokine binding | 1.72e-03 | 24 | 200 | 3 | GO:0019957 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-nitrogen bonds | 1.95e-03 | 53 | 200 | 4 | GO:0016879 | |
| GeneOntologyMolecularFunction | neuropeptide receptor activity | 1.95e-03 | 53 | 200 | 4 | GO:0008188 | |
| GeneOntologyMolecularFunction | G protein-coupled opioid receptor activity | 2.03e-03 | 7 | 200 | 2 | GO:0004985 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, NAD or NADP as acceptor | 2.03e-03 | 7 | 200 | 2 | GO:0016723 | |
| GeneOntologyMolecularFunction | guanyl-nucleotide exchange factor activity | 2.35e-03 | 231 | 200 | 8 | GO:0005085 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC17A2 PKD1L1 RYR1 SLC13A4 KCNK1 CACNA1B CACNA1E OPRM1 SLC6A13 SLC18A2 SLC17A8 ATP12A | 2.63e-03 | 465 | 200 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | C-X-C chemokine receptor activity | 2.69e-03 | 8 | 200 | 2 | GO:0016494 | |
| GeneOntologyMolecularFunction | retinoic acid binding | 2.70e-03 | 28 | 200 | 3 | GO:0001972 | |
| GeneOntologyMolecularFunction | ATPase-coupled intramembrane lipid transporter activity | 2.70e-03 | 28 | 200 | 3 | GO:0140326 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 3.43e-03 | 9 | 200 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 3.43e-03 | 9 | 200 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | protein kinase activator activity | 3.94e-03 | 149 | 200 | 6 | GO:0030295 | |
| GeneOntologyMolecularFunction | lipopeptide binding | 4.26e-03 | 10 | 200 | 2 | GO:0071723 | |
| GeneOntologyMolecularFunction | chemokine binding | 4.33e-03 | 33 | 200 | 3 | GO:0019956 | |
| GeneOntologyBiologicalProcess | G protein-coupled receptor signaling pathway | OR5AK2 CCR9 GPR52 ADCY5 OR1L3 FZD4 OR10G6 GPR83 RIC8A PLCB4 CCL13 OR8G5 OR5L2 NPBWR1 OR5V1 LPAR5 P2RY12 GPR35 ADGRL1 OR5AK3P OR8U3 OR8J1 ACKR4 GRM5 EDNRB OPRM1 OR8G1 OR2C1 OR12D3 P2RY6 CXCR6 OR51M1 FZD10 OR4C13 HCRTR2 | 2.17e-07 | 1395 | 201 | 35 | GO:0007186 |
| GeneOntologyBiologicalProcess | phospholipase C-activating G protein-coupled receptor signaling pathway | 6.36e-06 | 133 | 201 | 9 | GO:0007200 | |
| GeneOntologyBiologicalProcess | locomotory behavior | ABCA2 GPR52 ADCY5 FZD4 VPS13A CACNA1B CACNA1E DSCAM ALS2 GRM5 OPRM1 SLC18A2 | 2.38e-05 | 284 | 201 | 12 | GO:0007626 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus | OR5AK2 TLR6 OR1L3 OR10G6 OR8G5 OR5L2 OR5V1 OR5AK3P OR8U3 OR8J1 OR8G1 OR2C1 OR12D3 OR51M1 TLR1 OR4C13 | 5.87e-05 | 524 | 201 | 16 | GO:0009593 |
| GeneOntologyBiologicalProcess | detection of stimulus | OR5AK2 PKD1L1 NAIP GPR52 TLR6 OR1L3 OR10G6 OR8G5 OR5L2 OR5V1 OR5AK3P OR8U3 OR8J1 OR8G1 OR2C1 OR12D3 OR51M1 TLR1 OR4C13 | 8.75e-05 | 722 | 201 | 19 | GO:0051606 |
| GeneOntologyBiologicalProcess | detection of chemical stimulus involved in sensory perception of smell | OR5AK2 OR1L3 OR10G6 OR8G5 OR5L2 OR5V1 OR5AK3P OR8U3 OR8J1 OR8G1 OR2C1 OR12D3 OR51M1 OR4C13 | 9.20e-05 | 432 | 201 | 14 | GO:0050911 |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | SLC17A2 PKD1L1 RYR1 SLC13A4 KCNK1 PLCB4 CACNA1B CACNA1E CHERP P2RY12 GPR35 STEAP4 EDNRB OPRM1 SLC6A13 SLC15A2 P2RY6 SLC18A2 MCUR1 SLC17A8 STEAP3 ATP12A | 1.01e-04 | 922 | 201 | 22 | GO:0098662 |
| GeneOntologyCellularComponent | IgG immunoglobulin complex | 7.85e-06 | 14 | 202 | 4 | GO:0071735 | |
| GeneOntologyCellularComponent | IgD immunoglobulin complex | 1.74e-05 | 6 | 202 | 3 | GO:0071738 | |
| GeneOntologyCellularComponent | IgE immunoglobulin complex | 1.74e-05 | 6 | 202 | 3 | GO:0071742 | |
| GeneOntologyCellularComponent | PET complex | 2.77e-04 | 3 | 202 | 2 | GO:1990923 | |
| GeneOntologyCellularComponent | IgA immunoglobulin complex | 3.71e-04 | 15 | 202 | 3 | GO:0071745 | |
| GeneOntologyCellularComponent | IgM immunoglobulin complex | 3.71e-04 | 15 | 202 | 3 | GO:0071753 | |
| GeneOntologyCellularComponent | calcium channel complex | 7.07e-04 | 73 | 202 | 5 | GO:0034704 | |
| Domain | 7tm_1 | OR5AK2 CCR9 GPR52 OR1L3 OR10G6 GPR83 OR8G5 OR5L2 NPBWR1 OR5V1 LPAR5 P2RY12 GPR35 OR8U3 OR8J1 ACKR4 EDNRB OPRM1 OR8G1 OR2C1 OR12D3 P2RY6 CXCR6 OR51M1 OR4C13 HCRTR2 | 2.13e-08 | 677 | 202 | 26 | PF00001 |
| Domain | G_PROTEIN_RECEP_F1_1 | OR5AK2 CCR9 GPR52 OR1L3 OR10G6 GPR83 OR8G5 OR5L2 NPBWR1 OR5V1 LPAR5 P2RY12 GPR35 OR8U3 OR8J1 ACKR4 EDNRB OPRM1 OR8G1 OR2C1 OR12D3 P2RY6 CXCR6 OR51M1 OR4C13 HCRTR2 | 2.70e-08 | 685 | 202 | 26 | PS00237 |
| Domain | G_PROTEIN_RECEP_F1_2 | OR5AK2 CCR9 GPR52 OR1L3 OR10G6 GPR83 OR8G5 OR5L2 NPBWR1 OR5V1 LPAR5 P2RY12 GPR35 OR8U3 OR8J1 ACKR4 EDNRB OPRM1 OR8G1 OR2C1 OR12D3 P2RY6 CXCR6 OR51M1 OR4C13 HCRTR2 | 3.22e-08 | 691 | 202 | 26 | PS50262 |
| Domain | GPCR_Rhodpsn | OR5AK2 CCR9 GPR52 OR1L3 OR10G6 GPR83 OR8G5 OR5L2 NPBWR1 OR5V1 LPAR5 P2RY12 GPR35 OR8U3 OR8J1 ACKR4 EDNRB OPRM1 OR8G1 OR2C1 OR12D3 P2RY6 CXCR6 OR51M1 OR4C13 HCRTR2 | 3.31e-08 | 692 | 202 | 26 | IPR000276 |
| Domain | GPCR_Rhodpsn_7TM | OR5AK2 CCR9 GPR52 OR1L3 GPR83 OR8G5 OR5L2 NPBWR1 OR5V1 LPAR5 P2RY12 GPR35 OR8U3 OR8J1 ACKR4 EDNRB OPRM1 OR8G1 OR2C1 OR12D3 P2RY6 CXCR6 OR51M1 OR4C13 HCRTR2 | 7.11e-08 | 670 | 202 | 25 | IPR017452 |
| Domain | NPIP | 2.60e-07 | 14 | 202 | 5 | IPR009443 | |
| Domain | LRRC37AB_C | 4.95e-06 | 4 | 202 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 4.95e-06 | 4 | 202 | 3 | PF14914 | |
| Domain | LRRC37_N | 4.95e-06 | 4 | 202 | 3 | IPR032754 | |
| Domain | LRRC37 | 4.95e-06 | 4 | 202 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 4.95e-06 | 4 | 202 | 3 | IPR015753 | |
| Domain | MFS_dom | SLC17A2 SLCO1B3 MFSD4B SLC22A14 SLC16A9 SLC15A2 SLC18A2 SLC17A8 | 1.06e-04 | 134 | 202 | 8 | IPR020846 |
| Domain | Cyclin_Y | 1.16e-04 | 2 | 202 | 2 | IPR012399 | |
| Domain | MFS_1 | 1.86e-04 | 77 | 202 | 6 | PF07690 | |
| Domain | MFS | 1.86e-04 | 77 | 202 | 6 | IPR011701 | |
| Domain | CYCLINS | 2.22e-04 | 28 | 202 | 4 | PS00292 | |
| Domain | ABC_A | 2.55e-04 | 12 | 202 | 3 | IPR026082 | |
| Domain | - | 3.47e-04 | 3 | 202 | 2 | 2.40.270.10 | |
| Domain | RNA_pol_RPB2_OB-fold | 3.47e-04 | 3 | 202 | 2 | IPR014724 | |
| Domain | RNA_pol_bsu_CS | 3.47e-04 | 3 | 202 | 2 | IPR007121 | |
| Domain | DNA-dir_RNA_pol_su2_6 | 3.47e-04 | 3 | 202 | 2 | IPR007120 | |
| Domain | RNA_pol_Rpb2_7 | 3.47e-04 | 3 | 202 | 2 | PF04560 | |
| Domain | RNA_pol_Rpb2_2 | 3.47e-04 | 3 | 202 | 2 | PF04561 | |
| Domain | RNA_pol_Rpb2_5 | 3.47e-04 | 3 | 202 | 2 | PF04567 | |
| Domain | RNA_pol_Rpb2_1 | 3.47e-04 | 3 | 202 | 2 | PF04563 | |
| Domain | RNA_pol_Rpb2_3 | 3.47e-04 | 3 | 202 | 2 | PF04565 | |
| Domain | RNA_pol_Rpb2_5 | 3.47e-04 | 3 | 202 | 2 | IPR007647 | |
| Domain | RNA_pol_Rpb2_3 | 3.47e-04 | 3 | 202 | 2 | IPR007645 | |
| Domain | RNA_pol_bsu_protrusion | 3.47e-04 | 3 | 202 | 2 | IPR007644 | |
| Domain | RNA_pol_Rpb2_2 | 3.47e-04 | 3 | 202 | 2 | IPR007642 | |
| Domain | RNA_pol_Rpb2_7 | 3.47e-04 | 3 | 202 | 2 | IPR007641 | |
| Domain | - | 3.47e-04 | 3 | 202 | 2 | 2.40.50.150 | |
| Domain | RNA_POL_BETA | 3.47e-04 | 3 | 202 | 2 | PS01166 | |
| Domain | - | 3.47e-04 | 3 | 202 | 2 | 3.90.1110.10 | |
| Domain | DNA-dir_RNA_pol_su2 | 3.47e-04 | 3 | 202 | 2 | IPR015712 | |
| Domain | RNA_pol_Rpb2_6 | 3.47e-04 | 3 | 202 | 2 | PF00562 | |
| Domain | Olfact_rcpt | OR5AK2 OR1L3 OR10G6 OR8G5 OR5L2 OR5V1 OR8U3 OR8J1 OR8G1 OR2C1 OR12D3 OR51M1 OR4C13 | 3.65e-04 | 393 | 202 | 13 | IPR000725 |
| Domain | Cyclin_N | 4.25e-04 | 33 | 202 | 4 | PF00134 | |
| Domain | Cyclin_N | 4.25e-04 | 33 | 202 | 4 | IPR006671 | |
| Domain | Chemokine_rcpt | 6.29e-04 | 16 | 202 | 3 | IPR000355 | |
| Domain | Arylacetamide_deacetylase | 6.88e-04 | 4 | 202 | 2 | IPR017157 | |
| Domain | SHR-BD | 6.88e-04 | 4 | 202 | 2 | IPR009543 | |
| Domain | VPS13_C | 6.88e-04 | 4 | 202 | 2 | PF16909 | |
| Domain | VPS13_C | 6.88e-04 | 4 | 202 | 2 | IPR031645 | |
| Domain | SHR-BD | 6.88e-04 | 4 | 202 | 2 | PF06650 | |
| Domain | CYCLIN | 7.35e-04 | 38 | 202 | 4 | SM00385 | |
| Domain | - | 8.95e-04 | 40 | 202 | 4 | 1.10.472.10 | |
| Domain | RNaseH-like_dom | 9.03e-04 | 69 | 202 | 5 | IPR012337 | |
| Domain | AAA | 9.84e-04 | 144 | 202 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 9.84e-04 | 144 | 202 | 7 | IPR003593 | |
| Domain | Toll-like_receptor | 1.14e-03 | 5 | 202 | 2 | IPR017241 | |
| Domain | Autophagy-rel_C | 1.14e-03 | 5 | 202 | 2 | IPR015412 | |
| Domain | ATG_C | 1.14e-03 | 5 | 202 | 2 | PF09333 | |
| Domain | MFS | 1.14e-03 | 108 | 202 | 6 | PS50850 | |
| Domain | Cyclin-like | 1.18e-03 | 43 | 202 | 4 | IPR013763 | |
| Domain | UDPGT | 1.44e-03 | 21 | 202 | 3 | PF00201 | |
| Domain | - | 1.44e-03 | 21 | 202 | 3 | 1.10.2000.10 | |
| Domain | UDPGT | 1.44e-03 | 21 | 202 | 3 | PS00375 | |
| Domain | UDP_glucos_trans | 1.44e-03 | 21 | 202 | 3 | IPR002213 | |
| Domain | TIR | 1.44e-03 | 21 | 202 | 3 | SM00255 | |
| Domain | - | 1.65e-03 | 47 | 202 | 4 | 3.30.420.10 | |
| Domain | TIR | 1.65e-03 | 22 | 202 | 3 | PF01582 | |
| Domain | LIPASE_GDXG_SER | 1.70e-03 | 6 | 202 | 2 | PS01174 | |
| Domain | LIPASE_GDXG_HIS | 1.70e-03 | 6 | 202 | 2 | PS01173 | |
| Domain | DNA_pol3_clamp-load_cplx_C | 1.70e-03 | 6 | 202 | 2 | IPR008921 | |
| Domain | - | 1.88e-03 | 23 | 202 | 3 | 3.40.50.10140 | |
| Domain | TIR | 2.13e-03 | 24 | 202 | 3 | PS50104 | |
| Domain | Frizzled_dom | 2.13e-03 | 24 | 202 | 3 | IPR020067 | |
| Domain | FZ | 2.13e-03 | 24 | 202 | 3 | PS50038 | |
| Domain | Fz | 2.13e-03 | 24 | 202 | 3 | PF01392 | |
| Domain | ProC_N | 2.36e-03 | 7 | 202 | 2 | IPR028939 | |
| Domain | AB_hydrolase_3 | 2.36e-03 | 7 | 202 | 2 | IPR013094 | |
| Domain | Ca_chan_IQ | 2.36e-03 | 7 | 202 | 2 | SM01062 | |
| Domain | Ca_chan_IQ | 2.36e-03 | 7 | 202 | 2 | PF08763 | |
| Domain | Abhydrolase_3 | 2.36e-03 | 7 | 202 | 2 | PF07859 | |
| Domain | VDCC_a1su_IQ | 2.36e-03 | 7 | 202 | 2 | IPR014873 | |
| Domain | GPHH | 2.36e-03 | 7 | 202 | 2 | PF16905 | |
| Domain | F420_oxidored | 2.36e-03 | 7 | 202 | 2 | PF03807 | |
| Domain | GPHH_dom | 2.36e-03 | 7 | 202 | 2 | IPR031649 | |
| Domain | TIR_dom | 2.41e-03 | 25 | 202 | 3 | IPR000157 | |
| Domain | Glyco_trans_14 | 3.12e-03 | 8 | 202 | 2 | IPR003406 | |
| Domain | Chorein_N | 3.12e-03 | 8 | 202 | 2 | PF12624 | |
| Domain | VPS13_N | 3.12e-03 | 8 | 202 | 2 | IPR026854 | |
| Domain | MHC_II_b_N | 3.12e-03 | 8 | 202 | 2 | PD000328 | |
| Domain | Branch | 3.12e-03 | 8 | 202 | 2 | PF02485 | |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | CCR9 GPR52 GPR83 NPBWR1 OR5V1 LPAR5 P2RY12 GPR35 ACKR4 EDNRB OPRM1 OR2C1 OR12D3 P2RY6 HCRTR2 | 6.05e-08 | 260 | 143 | 15 | M39397 |
| Pathway | REACTOME_ATORVASTATIN_ADME | 1.27e-05 | 15 | 143 | 4 | MM15697 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC29A3 ABCA2 SLCO1B3 PSMD1 ATP9B MFSD4B ADCY5 RYR1 SLC13A4 NCEH1 AQP10 STEAP4 ATP8B2 SLC6A13 ABCA5 SLC15A2 SLC18A2 SLC25A1 SLC17A8 STEAP3 ATP12A | 1.64e-05 | 736 | 143 | 21 | M27287 |
| Pathway | WP_GPCRS_NONODORANT | CCR9 FZD4 NPBWR1 LPAR5 P2RY12 ADGRL1 GRM5 EDNRB OPRM1 P2RY6 CXCR6 HCRTR2 | 1.69e-05 | 266 | 143 | 12 | MM15843 |
| Pathway | WP_GPCRS_CLASS_A_RHODOPSINLIKE | 1.97e-05 | 186 | 143 | 10 | MM15994 | |
| Pathway | REACTOME_HEME_DEGRADATION | 4.34e-05 | 20 | 143 | 4 | MM14721 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | CCR9 FZD4 CCL13 NPBWR1 LPAR5 P2RY12 GPR35 ACKR4 GRM5 EDNRB OPRM1 P2RY6 CXCR6 FZD10 HCRTR2 | 7.22e-05 | 463 | 143 | 15 | M507 |
| Pathway | REACTOME_SIGNALING_BY_GPCR | CCR9 ADCY5 FZD4 GPR83 PLCB4 CCL13 NPBWR1 LPAR5 P2RY12 GPR35 ACKR4 GRM5 EDNRB OPRM1 P2RY6 CXCR6 FZD10 HCRTR2 SOS1 | 8.72e-05 | 702 | 143 | 19 | M746 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | CCR9 CCL13 NPBWR1 LPAR5 P2RY12 GPR35 ACKR4 EDNRB OPRM1 P2RY6 CXCR6 HCRTR2 | 1.36e-04 | 330 | 143 | 12 | M18334 |
| Pathway | REACTOME_CLASS_A_1_RHODOPSIN_LIKE_RECEPTORS | CCR9 CCL13 NPBWR1 LPAR5 P2RY12 GPR35 ACKR4 EDNRB OPRM1 P2RY6 CXCR6 HCRTR2 | 1.48e-04 | 333 | 143 | 12 | MM14963 |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 1.59e-04 | 11 | 143 | 3 | M47958 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC29A3 ABCA2 SLCO1B3 PSMD1 ATP9B RYR1 SLC13A4 NCEH1 STEAP4 ATP8B2 SLC6A13 ABCA5 SLC15A2 SLC18A2 SLC25A1 SLC17A8 STEAP3 ATP12A | 1.82e-04 | 681 | 143 | 18 | MM14985 |
| Pathway | REACTOME_METABOLISM_OF_PORPHYRINS | 2.93e-04 | 32 | 143 | 4 | MM14719 | |
| Pathway | REACTOME_SIGNALING_BY_GPCR | CCR9 ADCY5 GPR83 PLCB4 CCL13 NPBWR1 LPAR5 P2RY12 GPR35 ACKR4 GRM5 EDNRB OPRM1 P2RY6 CXCR6 HCRTR2 SOS1 | 2.93e-04 | 646 | 143 | 17 | MM14962 |
| Pathway | REACTOME_OLFACTORY_SIGNALING_PATHWAY | OR5AK2 OR1L3 OR10G6 OR8G5 OR5L2 OR5V1 OR8U3 OR8J1 OR8G1 OR2C1 OR12D3 OR51M1 OR4C13 | 3.24e-04 | 417 | 143 | 13 | M4072 |
| Pathway | REACTOME_NETRIN_1_SIGNALING | 4.25e-04 | 15 | 143 | 3 | MM14965 | |
| Pathway | REACTOME_GPCR_LIGAND_BINDING | CCR9 CCL13 NPBWR1 LPAR5 P2RY12 GPR35 ACKR4 GRM5 EDNRB OPRM1 P2RY6 CXCR6 HCRTR2 | 4.34e-04 | 430 | 143 | 13 | MM15160 |
| Pubmed | Novel retinal and cone photoreceptor transcripts revealed by human macular expression profiling. | 1.32e-09 | 4 | 211 | 4 | 18055785 | |
| Pubmed | 9.04e-08 | 8 | 211 | 4 | 3122211 | ||
| Pubmed | Clustered arrangement of immunoglobulin lambda constant region genes in man. | 1.62e-07 | 9 | 211 | 4 | 6273747 | |
| Pubmed | Different evolutionary processes shaped the mouse and human olfactory receptor gene families. | OR5AK2 OR10G6 OR8G5 OR5L2 OR5V1 OR5AK3P OR8U3 OR8J1 OR8G1 OR2C1 OR12D3 OR51M1 OR4C13 | 1.89e-07 | 340 | 211 | 13 | 11875048 |
| Pubmed | OR5AK2 OR10G6 OR8G5 OR5L2 OR5V1 OR5AK3P OR8U3 OR8J1 OR8G1 OR2C1 OR12D3 OR51M1 OR4C13 | 1.89e-07 | 340 | 211 | 13 | 11802173 | |
| Pubmed | OR5AK2 OR10G6 OR8G5 OR5L2 OR5V1 OR5AK3P OR8U3 OR8J1 OR8G1 OR2C1 OR12D3 OR51M1 OR4C13 | 2.09e-07 | 343 | 211 | 13 | 32295537 | |
| Pubmed | 2.20e-07 | 3 | 211 | 3 | 12077254 | ||
| Pubmed | 2.20e-07 | 3 | 211 | 3 | 2515285 | ||
| Pubmed | OR5AK2 OR10G6 OR8G5 OR5L2 OR5V1 OR5AK3P OR8U3 OR8J1 OR8G1 OR2C1 OR12D3 OR51M1 OR4C13 | 2.31e-07 | 346 | 211 | 13 | 14611657 | |
| Pubmed | 2.69e-07 | 10 | 211 | 4 | 23371916 | ||
| Pubmed | 6.27e-07 | 12 | 211 | 4 | 19419973 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 4215080 | ||
| Pubmed | Immunoglobulin lambda-chains. The complete amino acid sequence of a Bence-Jones protein. | 8.77e-07 | 4 | 211 | 3 | 4883841 | |
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 22419166 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 6404900 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 4415202 | ||
| Pubmed | 8.77e-07 | 4 | 211 | 3 | 5549568 | ||
| Pubmed | Multiple variable first exons: a mechanism for cell- and tissue-specific gene regulation. | 1.26e-06 | 14 | 211 | 4 | 14672974 | |
| Pubmed | 1.71e-06 | 15 | 211 | 4 | 20176268 | ||
| Pubmed | Amino acid sequence of the (lambda) light chain of a human myeloma immunoglobulin (IgG New). | 2.18e-06 | 5 | 211 | 3 | 4814727 | |
| Pubmed | 2.18e-06 | 5 | 211 | 3 | 4909564 | ||
| Pubmed | Genome-wide association of serum bilirubin levels in Korean population. | 2.95e-06 | 17 | 211 | 4 | 20639394 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | ABCA2 RYR1 SH3BP4 ZER1 RIC8A PLK3 ALOX5 RIC1 LPAR5 VPS39 PHF12 HECTD4 ADGRL1 SPATA20 GET4 INF2 STEAP3 PCNX1 WDFY3 HAS3 DHX34 | 4.31e-06 | 1105 | 211 | 21 | 35748872 |
| Pubmed | MAIT cell activation augments adenovirus vector vaccine immunogenicity. | 4.34e-06 | 6 | 211 | 3 | 33510029 | |
| Pubmed | 4.34e-06 | 6 | 211 | 3 | 26669262 | ||
| Pubmed | Characterization of the two unique human anti-flavin monoclonal immunoglobulins. | 1.21e-05 | 8 | 211 | 3 | 7737190 | |
| Pubmed | 1.21e-05 | 8 | 211 | 3 | 27069113 | ||
| Pubmed | Genetic determinants influencing human serum metabolome among African Americans. | 1.27e-05 | 24 | 211 | 4 | 24625756 | |
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 22511988 | ||
| Pubmed | T helper 1 effector memory CD4+ TÂ cells protect the skin from poxvirus infection. | 1.80e-05 | 9 | 211 | 3 | 37083328 | |
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 1339448 | ||
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 15128825 | ||
| Pubmed | Structure and expression of the human immunoglobulin lambda genes. | 1.80e-05 | 9 | 211 | 3 | 2115572 | |
| Pubmed | 1.80e-05 | 9 | 211 | 3 | 36736322 | ||
| Pubmed | 2.56e-05 | 10 | 211 | 3 | 23642732 | ||
| Pubmed | 2.56e-05 | 10 | 211 | 3 | 23064749 | ||
| Pubmed | 2.56e-05 | 10 | 211 | 3 | 11465080 | ||
| Pubmed | A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemia. | 2.56e-05 | 10 | 211 | 3 | 22558097 | |
| Pubmed | 2.78e-05 | 29 | 211 | 4 | 34678150 | ||
| Pubmed | OR5AK2 OR1L3 OR10G6 OR8G5 OR5L2 OR5V1 OR8U3 OR8J1 OR8G1 OR2C1 OR12D3 OR51M1 OR4C13 | 2.99e-05 | 541 | 211 | 13 | 14983052 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 35931226 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 22315281 | ||
| Pubmed | Feasibility and biological rationale of repurposing sunitinib and erlotinib for dengue treatment. | 3.66e-05 | 2 | 211 | 2 | 29753658 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 21454501 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 8068691 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 15610184 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 26470427 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 9525580 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 21852947 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 14990690 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 24641623 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 27974562 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 33101303 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 33173007 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 29234073 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 29378173 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 11123271 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 21645617 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 22908290 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 33149141 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 17935177 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 29175392 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 22933295 | ||
| Pubmed | Exonuclease Domain-Containing 1 Enhances MIWI2 piRNA Biogenesis via Its Interaction with TDRD12. | 3.66e-05 | 2 | 211 | 2 | 30257204 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 28474755 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 22973027 | ||
| Pubmed | Meningeal lymphatic vessels mediate neurotropic viral drainage from the central nervous system. | 3.66e-05 | 2 | 211 | 2 | 35524140 | |
| Pubmed | Dynamic roles of type I and type II IFNs in early infection with Mycobacterium tuberculosis. | 3.66e-05 | 2 | 211 | 2 | 22566567 | |
| Pubmed | Modified mRNA Vaccines Protect against Zika Virus Infection. | 3.66e-05 | 2 | 211 | 2 | 28222903 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 10714556 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 28199846 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 32873747 | ||
| Pubmed | A Dengue Virus Type 4 Model of Disseminated Lethal Infection in AG129 Mice. | 3.66e-05 | 2 | 211 | 2 | 25938762 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 34730391 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 35862771 | ||
| Pubmed | Mice lacking alpha/beta and gamma interferon receptors are susceptible to junin virus infection. | 3.66e-05 | 2 | 211 | 2 | 20926559 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 22815273 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 38086794 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 16585541 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 23960239 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 22130542 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 22419801 | ||
| Pubmed | A Mouse Model of PPRV Infection for Elucidating Protective and Pathological Roles of Immune Cells. | 3.66e-05 | 2 | 211 | 2 | 33912160 | |
| Pubmed | Role of TLR1 and TLR6 in the host defense against disseminated candidiasis. | 3.66e-05 | 2 | 211 | 2 | 18036178 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 24445834 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 30002446 | ||
| Pubmed | Positive selection of a gene family during the emergence of humans and African apes. | 3.66e-05 | 2 | 211 | 2 | 11586358 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 31243154 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 17591617 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 24984237 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 36417857 | ||
| Pubmed | Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. | 3.66e-05 | 2 | 211 | 2 | 20592088 | |
| Pubmed | Functional interferon system is required for clearance of lassa virus. | 3.66e-05 | 2 | 211 | 2 | 22238311 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 22396045 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 15016885 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 31896593 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 25261617 | ||
| Pubmed | Adaptation of enterovirus 71 to adult interferon deficient mice. | 3.66e-05 | 2 | 211 | 2 | 23527208 | |
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 9687534 | ||
| Pubmed | 3.66e-05 | 2 | 211 | 2 | 22131327 | ||
| Cytoband | 16p13.11 | 6.15e-08 | 23 | 211 | 5 | 16p13.11 | |
| GeneFamily | Cyclins | 7.98e-05 | 28 | 150 | 4 | 473 | |
| GeneFamily | Solute carriers | SLC17A2 SLC29A3 SLCO1B3 SLC13A4 SLC35F3 SLC22A14 SLC16A9 SLC6A13 SLC15A2 SLC18A2 SLC25A1 SLC17A8 | 1.15e-04 | 395 | 150 | 12 | 752 |
| GeneFamily | ATP binding cassette subfamily A | 1.91e-04 | 14 | 150 | 3 | 805 | |
| GeneFamily | Interferon receptors | 6.73e-04 | 5 | 150 | 2 | 599 | |
| GeneFamily | Proteases, serine|STEAP family | 6.73e-04 | 5 | 150 | 2 | 1324 | |
| GeneFamily | Glucosaminyl (N-acetyl) transferases/xylosyltransferases | 1.85e-03 | 8 | 150 | 2 | 441 | |
| GeneFamily | UDP glucuronosyltransferases | 2.33e-03 | 32 | 150 | 3 | 363 | |
| GeneFamily | Olfactory receptors, family 5 | 2.42e-03 | 112 | 150 | 5 | 152 | |
| GeneFamily | CD molecules|Toll like receptors | 2.95e-03 | 10 | 150 | 2 | 948 | |
| GeneFamily | Purinergic receptors P2Y | 2.95e-03 | 10 | 150 | 2 | 213 | |
| GeneFamily | G protein-coupled receptors, Class F frizzled | 3.58e-03 | 11 | 150 | 2 | 286 | |
| Coexpression | GSE15750_WT_VS_TRAF6KO_DAY10_EFF_CD8_TCELL_UP | RPP40 SQLE TLR6 TBC1D32 RECQL5 ZER1 ALOX5 HEATR3 SLC15A2 HCRTR2 | 4.44e-06 | 200 | 206 | 10 | M3573 |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | EXD1 RYR1 DNAH9 CACNA1B CACNA1E SLC16A9 DSCAM ASS1 PDZD2 TDRD12 | 7.40e-09 | 167 | 210 | 10 | 3edb0570e583bb527165bcd8a4c25a042054043b |
| ToppCell | droplet-Kidney-KIDNEY-30m-Epithelial-Epcam____brush_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-06 | 162 | 210 | 8 | de0fde4310a56dc96bfc134c44d104993526d9bc | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|390C / Donor, Lineage, Cell class and subclass (all cells) | 1.45e-06 | 169 | 210 | 8 | 2c851b2703c7b8b656026f996f5fc027e4a79b36 | |
| ToppCell | 390C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.72e-06 | 173 | 210 | 8 | 1f725ff16e28636b20ef26f3fa9be8b47c89378d | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 176 | 210 | 8 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.96e-06 | 176 | 210 | 8 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | myeloid-Dendritic_cell-Plasmacytoid_dendritic_cell|myeloid / Lineage, cell class and subclass | 2.13e-06 | 178 | 210 | 8 | f75591988bbbeba073b66329a3437cb9b02f7648 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 180 | 210 | 8 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 180 | 210 | 8 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-06 | 180 | 210 | 8 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.73e-06 | 184 | 210 | 8 | 1c56378b3888c46258d446b47de4d6282fe74b0d | |
| ToppCell | BAL-Severe-Myeloid-cDC-cDC-cDC_3|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.73e-06 | 184 | 210 | 8 | a45980306c4e697a2703bed72a7b48fb23d942f4 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.47e-06 | 134 | 210 | 7 | d29ac8152dc581c0da2430d06cd259ac0eded808 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.47e-06 | 134 | 210 | 7 | 459c39df15d3cf9144ce7827e8d14830d31353bb | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)-|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.47e-06 | 134 | 210 | 7 | d065449ca3679e4818b74fb7302cc7f1ce62f691 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP-Dcn_1-Dcn_1_1-Endothelial_Tip.Dcn.Apod_(Apod)|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 3.47e-06 | 134 | 210 | 7 | 0be389f416818a22e80098dd809fdf45b14171e8 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.88e-06 | 193 | 210 | 8 | 71bf8fb5314b79cb30f4eb9c8459b21f10cd6d35 | |
| ToppCell | cellseq-Epithelial-Epithelial_Glandular-Goblet-Goblet|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.88e-06 | 193 | 210 | 8 | b05e110b13d35d34294357c8e1c4fd23bf4b6c92 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 4.87e-06 | 199 | 210 | 8 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Mucous|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.05e-06 | 200 | 210 | 8 | ed093626a9cac7531a2bf02f6e345c5e84b8c060 | |
| ToppCell | Tracheal-10x5prime-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 5.05e-06 | 200 | 210 | 8 | 27f498bcd706d0751091662996795b5270e46f14 | |
| ToppCell | Frontal_cortex-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Fezf2|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 5.92e-06 | 95 | 210 | 6 | ffbf3e362384c87b9db690ed39cd215e1f68375c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.07e-05 | 159 | 210 | 7 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | Healthy/Control-Treg|World / Disease group and Cell class | 1.16e-05 | 161 | 210 | 7 | 457297cda5c9cee3bcc069fdecbbe24def027e5f | |
| ToppCell | Children_(3_yrs)-Immune-dendritic_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-05 | 161 | 210 | 7 | cd41abb7ae659d3d314281783a0aaad562b26037 | |
| ToppCell | tumor_Lung-Myeloid_cells-Pleural_Mac|tumor_Lung / Location, Cell class and cell subclass | 1.21e-05 | 162 | 210 | 7 | 9ac3242511315224ed94582aca9e9a3786cd01a0 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.59e-05 | 169 | 210 | 7 | 40b557549fe08c5dc9dba359af35993d68d1640a | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 171 | 210 | 7 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.71e-05 | 171 | 210 | 7 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 175 | 210 | 7 | 076ad81d6cbeea5512393d192af3ab5aa1f82975 | |
| ToppCell | 390C-Lymphocytic-NK_cells-NK_cell_A2|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.99e-05 | 175 | 210 | 7 | da191dfb8a7f976a632a3a0b923942ab54f5c8c1 | |
| ToppCell | facs-Kidney-nan-18m-Epithelial-epithelial_cell_of_proximal_tubule|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.99e-05 | 175 | 210 | 7 | 445ccb9744a3a9ff37164c532afbe769d306b6c8 | |
| ToppCell | ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, Lineage and Cell Type | 2.14e-05 | 177 | 210 | 7 | 33cd2c183ee8b597012efcbcae72131ac6beaf4e | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Myeloid-macrophage_dendritic_cell_progenitor|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-05 | 178 | 210 | 7 | 742ee0cb8cb585a5e34bd5b20aebe9bb99756e0c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.30e-05 | 179 | 210 | 7 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-Interstitial_Macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 179 | 210 | 7 | 6eb84fe9691ad40127b2d1f1c672428333c8fab4 | |
| ToppCell | droplet-Lung-immune-endo-depleted-3m-Myeloid-lung_macrophage|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.30e-05 | 179 | 210 | 7 | 2c3abd646d2c8992e8ff76a824eab5beba8ba4c6 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 180 | 210 | 7 | 67b062f2ef7e20f392e00c646f4985c415d40de9 | |
| ToppCell | severe-Myeloid-Eosinophils|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 2.38e-05 | 180 | 210 | 7 | ac03812b1409435c55d323a7516deeac82bd3509 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.38e-05 | 180 | 210 | 7 | b28363626f4d2a552abde3434cc1df2e2121aba5 | |
| ToppCell | LV|World / Chamber and Cluster_Paper | 2.38e-05 | 180 | 210 | 7 | 5ac6f485a58bb29462fec02dfbe8eb70864eafe3 | |
| ToppCell | COVID-19-Heart-Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.47e-05 | 181 | 210 | 7 | 33cac65ed1ea5e7bd72250495df4f850b143d5aa | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.48e-05 | 122 | 210 | 6 | 7dabf8b4c34a3714f45c3a99c1aa159e2d0b7e9c | |
| ToppCell | PBMC-Mild-Myeloid-cDC-cDC-cDC_9|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.48e-05 | 122 | 210 | 6 | 489a01c71882be5a6d71a19d06574698988c20f6 | |
| ToppCell | Posterior_cortex-Endothelial-ENDOTHELIAL_TIP-Dcn_1|Posterior_cortex / BrainAtlas - Mouse McCarroll V32 | 2.60e-05 | 123 | 210 | 6 | 28be15b759c152662b29c323b1cc3f02f7830dbe | |
| ToppCell | Control-Endothelial-Endothelial-Activated_Alv_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-05 | 183 | 210 | 7 | e81c142770f44fd902b0631bc360c5b5339d4c75 | |
| ToppCell | PBMC-Mild-cDC_9|Mild / Compartment, Disease Groups and Clusters | 2.74e-05 | 184 | 210 | 7 | 2e0c9a2c40c892a2d435eafb31f1f838de9baf15 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.84e-05 | 185 | 210 | 7 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | 3'_v3-blood-Myeloid_Dendritic-DC1|blood / Manually curated celltypes from each tissue | 3.15e-05 | 188 | 210 | 7 | 411d4dd5c9dee7ebd8db352640cf009e7b033ba9 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.37e-05 | 190 | 210 | 7 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | Fetal_29-31_weeks-Immune-B_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.37e-05 | 190 | 210 | 7 | 424550418c1bd4eb070cf3c41cf09fa9d89aef37 | |
| ToppCell | BL-critical-LOC-Epithelial-Secretory|LOC / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.37e-05 | 190 | 210 | 7 | f2abe4bc28e934287e2dcd7b9399d5af78c5c8cf | |
| ToppCell | wk_20-22-Hematologic_Lymphocytic-B-Late_pre-B|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 3.48e-05 | 191 | 210 | 7 | 2b05be1888cccd03a32341bcb1de4a899d4179fd | |
| ToppCell | COVID-19-Myeloid-DC2|COVID-19 / Condition, Lineage and Cell class | 3.48e-05 | 191 | 210 | 7 | 1304ab7b5713f29f3966ffc020ea1b52e8e2f375 | |
| ToppCell | tumor_Lung|World / Location, Cell class and cell subclass | 3.84e-05 | 194 | 210 | 7 | 7e6b8a30f8d08252ad3f1df826d6f7c0ba997c2c | |
| ToppCell | COVID_vent-Myeloid-Monocytic-Neutrophil|COVID_vent / Disease condition, Lineage, Cell class and subclass | 3.84e-05 | 194 | 210 | 7 | eb23b171e429165dd26a64377eae7fa2ce25f547 | |
| ToppCell | proximal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.97e-05 | 195 | 210 | 7 | 8592d0332bc82a91e173680cfd1afc5ee189b289 | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.97e-05 | 195 | 210 | 7 | c48ff83c48342875f06c6c9e7d5bc6084a992848 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-05 | 195 | 210 | 7 | ff9f6b38f41dc5660b746fe40ceaddfb2958acd3 | |
| ToppCell | proximal-Hematologic-IGSF21+_Dendritic-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.97e-05 | 195 | 210 | 7 | ae9d61011e95f7840cbb154738c79745fd29943e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-05 | 195 | 210 | 7 | ffbab350e67d9c4b66c0ab84550daec8b8139a27 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-club_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-05 | 195 | 210 | 7 | 460e12044905370797fd9774e99c3aedaebfe343 | |
| ToppCell | 3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)-Club_(non-nasal)_L.0.4.0.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.10e-05 | 196 | 210 | 7 | 1ff4b41817556a6e573f0737819a5cc24a7ef821 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.10e-05 | 196 | 210 | 7 | e819088a74d29e958371aa851ac9c74ec55367b7 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.10e-05 | 196 | 210 | 7 | e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.10e-05 | 196 | 210 | 7 | c18874f37b90e6afacc562b2082b67ea8a7cb4a4 | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.10e-05 | 196 | 210 | 7 | a4d05d85fbafa869df19bba3881020ea433d81fb | |
| ToppCell | BAL-Mild-Epithelial-Epithelial-Basal/Club-|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 4.10e-05 | 196 | 210 | 7 | 91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05 | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Dendritic_cell-DC_2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.10e-05 | 196 | 210 | 7 | 8862964090f9a679a548103bfbb12e91295aae62 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.24e-05 | 197 | 210 | 7 | a357ee2ba9100dfaeba9ecae8138a2776bb54b0b | |
| ToppCell | distal-3-Epithelial-Goblet|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 4.24e-05 | 197 | 210 | 7 | a00784ccfb1de6a96b91e2a8a2889b69f31a33da | |
| ToppCell | Bronchial-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.24e-05 | 197 | 210 | 7 | 0a404b4494a2246d5a92299235056f0fda4d2b48 | |
| ToppCell | wk_15-18-Hematologic-Myeloid-CX3CR1+_Mac|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 4.24e-05 | 197 | 210 | 7 | 701334bc164e3b41132232f27574a87e9c3a5be5 | |
| ToppCell | AT2_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 4.24e-05 | 197 | 210 | 7 | 8b5d4e1c33a57c899c51feb9a6f347232f8910a3 | |
| ToppCell | Mild_COVID-19-Epithelial-Basal/Club|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 4.24e-05 | 197 | 210 | 7 | 4cc5b778e1e2c6c149160fa147c172977c0fa8eb | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macro_CHIT1|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.37e-05 | 198 | 210 | 7 | 243109377d62d20c69e9d1fedc252156e90cda1e | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell-Epi-Secretory|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.37e-05 | 198 | 210 | 7 | 270cecff42b87b7e03f09dd9f99547b287b4598c | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Epithelial-Epithelial,_Airway-secretory_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.37e-05 | 198 | 210 | 7 | 8b3f4effaaccf8777cde854d5d8a765962f7312b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.38e-05 | 135 | 210 | 6 | 9f9d0787a2e99207a9caa88a85565189ab8b940a | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5B+|Biopsy_Other_PF / Sample group, Lineage and Cell type | 4.52e-05 | 199 | 210 | 7 | afd0df242a93f176438309668a9487be1250d9ca | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.52e-05 | 199 | 210 | 7 | 744b63fba33b176ab7dde11646ccb313665505f7 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-MUC5B+|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 4.52e-05 | 199 | 210 | 7 | 4ab45996e6bca406c77895a5998982b8ab1cf210 | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5AC+_High|Biopsy_IPF / Sample group, Lineage and Cell type | 4.52e-05 | 199 | 210 | 7 | 51cb306e36537a53968c55187bd87c83e1706187 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.66e-05 | 200 | 210 | 7 | 179afc4bee7a2fd85a3b5dadf32544a63807c164 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_submucosal-gland-SMG_Duct|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.66e-05 | 200 | 210 | 7 | b992eeddee38e6fe3564e9b1850f6b20b89bf47d | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Myeloid-Macrophage_other-Macrophage_intravascular|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 4.66e-05 | 200 | 210 | 7 | 4b4df0fe47498310d94448b8a289e58e4f5b5aa8 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-Club|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 4.66e-05 | 200 | 210 | 7 | 85f946dd3831acf3488c87efba96689cc2667c3a | |
| ToppCell | Biopsy_IPF-Epithelial-MUC5B+|Biopsy_IPF / Sample group, Lineage and Cell type | 4.66e-05 | 200 | 210 | 7 | f0a6747f6d37ec6d261bd649ac678c39cca5e4c8 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.66e-05 | 200 | 210 | 7 | 8a44a4f7ea9358f2194a490e79601c98ff7fdcb0 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-Club|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 4.66e-05 | 200 | 210 | 7 | 30d428510c68da96c7c8cfd472f449ebb9631132 | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.66e-05 | 200 | 210 | 7 | 72c1d9eeaed4b3ee6b6c602e8aa29efc2e8744eb | |
| ToppCell | LPS_IL1RA_TNF-Epithelial_airway-airway_epithelial|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 4.66e-05 | 200 | 210 | 7 | da12821e8a0657869ca0f75d351cce2d7605a505 | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-cDC1|ICU-NoSEP / Disease, condition lineage and cell class | 4.66e-05 | 200 | 210 | 7 | 511e642575182fb678df6791ee6539b0ced3eb17 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.04e-05 | 147 | 210 | 6 | 1ecd7c084e73eb6fae1ab1f9aae17115d3d62cbd | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-05 | 147 | 210 | 6 | 9d7e965fe61bd7b31e09c4b2129a5a98c36f4811 | |
| ToppCell | facs-Marrow-B-cells-24m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.04e-05 | 147 | 210 | 6 | 38552953ff65a0fc20bee6ef57dc5885306ad18b | |
| ToppCell | facs-Lung-3m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.59e-05 | 149 | 210 | 6 | efa30fcd9370f98eb7445f295eb4d0305ff455c3 | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-05 | 149 | 210 | 6 | 1527cdd98a2734cbf8ce4c6170557280b71c55cb | |
| ToppCell | LPS-antiTNF-Hematopoietic_Mast-Mast_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.59e-05 | 149 | 210 | 6 | 59aa1f2a5cbeba64c4529fb05f544db17fd8b188 | |
| ToppCell | Cerebellum-Endothelial-ENDOTHELIAL_TIP|Cerebellum / BrainAtlas - Mouse McCarroll V32 | 7.59e-05 | 149 | 210 | 6 | 3980fa4f1986a2f164a1826ea043fb71f1d756cd | |
| Disease | cholelithiasis | 2.44e-06 | 88 | 201 | 7 | EFO_0004799 | |
| Disease | Down syndrome (implicated_via_orthology) | 2.69e-06 | 15 | 201 | 4 | DOID:14250 (implicated_via_orthology) | |
| Disease | urate measurement, spine bone mineral density | 2.79e-06 | 58 | 201 | 6 | EFO_0004531, EFO_0007701 | |
| Disease | RS-warfarin measurement | 2.87e-06 | 128 | 201 | 8 | EFO_0803325 | |
| Disease | X-11793--oxidized bilirubin measurement | 1.70e-05 | 8 | 201 | 3 | EFO_0021260 | |
| Disease | Succinimide measurement | 1.70e-05 | 8 | 201 | 3 | EFO_0022118 | |
| Disease | X-11530 measurement | 1.70e-05 | 8 | 201 | 3 | EFO_0021249 | |
| Disease | sulfate of piperine metabolite C16H19NO3 (2) measurement | 1.70e-05 | 8 | 201 | 3 | EFO_0801034 | |
| Disease | cholelithiasis, bilirubin measurement | 1.70e-05 | 8 | 201 | 3 | EFO_0004570, EFO_0004799 | |
| Disease | X-11522 measurement | 1.70e-05 | 8 | 201 | 3 | EFO_0800696 | |
| Disease | X-10458 measurement | 1.70e-05 | 8 | 201 | 3 | EFO_0800692 | |
| Disease | X-24849 measurement | 1.70e-05 | 8 | 201 | 3 | EFO_0800909 | |
| Disease | membrane-associated progesterone receptor component 1 measurement | 1.70e-05 | 8 | 201 | 3 | EFO_0802740 | |
| Disease | X-16946 measurement | 1.70e-05 | 8 | 201 | 3 | EFO_0800766 | |
| Disease | asthma, allergic disease | 1.70e-05 | 79 | 201 | 6 | MONDO_0004979, MONDO_0005271 | |
| Disease | X-11442 measurement | 2.54e-05 | 9 | 201 | 3 | EFO_0021236 | |
| Disease | X-11441 measurement | 2.54e-05 | 9 | 201 | 3 | EFO_0021235 | |
| Disease | circulating cell free DNA measurement | 2.54e-05 | 9 | 201 | 3 | EFO_0004739 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (3) measurement | 2.54e-05 | 9 | 201 | 3 | EFO_0801037 | |
| Disease | sulfate of piperine metabolite C18H21NO3 (1) measurement | 2.54e-05 | 9 | 201 | 3 | EFO_0801036 | |
| Disease | X-11880 measurement | 2.54e-05 | 9 | 201 | 3 | EFO_0800698 | |
| Disease | protein-tyrosine kinase 6 measurement | 2.54e-05 | 9 | 201 | 3 | EFO_0020691 | |
| Disease | testis-specific chromodomain protein Y 1 measurement | 2.54e-05 | 9 | 201 | 3 | EFO_0802127 | |
| Disease | bilirubin measurement, response to xenobiotic stimulus | 2.54e-05 | 9 | 201 | 3 | EFO_0004570, GO_0009410 | |
| Disease | bilirubin measurement, response to tenofovir | 3.61e-05 | 10 | 201 | 3 | EFO_0004570, EFO_0009279 | |
| Disease | X-21448 measurement | 3.61e-05 | 10 | 201 | 3 | EFO_0800816 | |
| Disease | UDP-glucuronosyltransferase 1-6 measurement | 3.61e-05 | 10 | 201 | 3 | EFO_0802185 | |
| Disease | X-23974 measurement | 3.61e-05 | 10 | 201 | 3 | EFO_0800867 | |
| Disease | tuberculosis (is_implicated_in) | 3.76e-05 | 28 | 201 | 4 | DOID:399 (is_implicated_in) | |
| Disease | histidine betaine (hercynine) measurement | 4.94e-05 | 11 | 201 | 3 | EFO_0800972 | |
| Disease | X-21796 measurement | 4.94e-05 | 11 | 201 | 3 | EFO_0800825 | |
| Disease | insomnia, bilirubin measurement | 4.94e-05 | 11 | 201 | 3 | EFO_0004570, EFO_0004698 | |
| Disease | aldosterone measurement | 4.94e-05 | 11 | 201 | 3 | EFO_0010219 | |
| Disease | p-cresol glucuronide measurement | 6.55e-05 | 12 | 201 | 3 | EFO_0800079 | |
| Disease | biliverdin measurement | 6.55e-05 | 12 | 201 | 3 | EFO_0021033 | |
| Disease | phosphatidylcholine 40:7 measurement | 8.47e-05 | 13 | 201 | 3 | EFO_0021477 | |
| Disease | retinol dehydrogenase 16 measurement | 8.47e-05 | 13 | 201 | 3 | EFO_0802007 | |
| Disease | gallstones | 9.97e-05 | 108 | 201 | 6 | EFO_0004210 | |
| Disease | asthma (is_implicated_in) | 1.05e-04 | 157 | 201 | 7 | DOID:2841 (is_implicated_in) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 1.38e-04 | 3 | 201 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.38e-04 | 3 | 201 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | juvenile idiopathic arthritis | 1.54e-04 | 74 | 201 | 5 | EFO_0002609 | |
| Disease | low density lipoprotein cholesterol measurement, body fat percentage | 1.97e-04 | 17 | 201 | 3 | EFO_0004611, EFO_0007800 | |
| Disease | X-21441 measurement | 1.97e-04 | 17 | 201 | 3 | EFO_0800814 | |
| Disease | angiopoietin-related protein 1 measurement | 2.36e-04 | 18 | 201 | 3 | EFO_0801382 | |
| Disease | migraine (implicated_via_orthology) | 2.75e-04 | 4 | 201 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | unipolar depression, smoking behaviour measurement | 2.75e-04 | 4 | 201 | 2 | EFO_0003761, EFO_0005671 | |
| Disease | Treacher Collins syndrome | 2.75e-04 | 4 | 201 | 2 | cv:C0242387 | |
| Disease | type 1 diabetes mellitus, latent autoimmune diabetes in adults | 2.75e-04 | 4 | 201 | 2 | EFO_0009706, MONDO_0005147 | |
| Disease | skin hydration measurement | 3.78e-04 | 21 | 201 | 3 | EFO_0009586 | |
| Disease | tissue factor measurement | 3.78e-04 | 21 | 201 | 3 | EFO_0010623 | |
| Disease | response to trauma exposure | 4.07e-04 | 51 | 201 | 4 | EFO_0008483 | |
| Disease | Malignant neoplasm of breast | GABRP BRIP1 CATSPERE LRRC37A2 CCND1 DTX3L INPP4B LRRC37A RIC8A DNAH9 NPBWR1 VPS39 PHF7 THOC5 EDNRB OR12D3 G6PC1 VPS13B | 4.26e-04 | 1074 | 201 | 18 | C0006142 |
| Disease | asthma exacerbation measurement | 4.46e-04 | 93 | 201 | 5 | EFO_0007614 | |
| Disease | choreatic disease (is_implicated_in) | 4.56e-04 | 5 | 201 | 2 | DOID:12859 (is_implicated_in) | |
| Disease | narcolepsy-cataplexy syndrome, age at onset | 4.56e-04 | 5 | 201 | 2 | EFO_0004847, MONDO_0016158 | |
| Disease | Mandibulofacial dysostosis | 4.56e-04 | 5 | 201 | 2 | cv:CN004722 | |
| Disease | HPV seropositivity | 4.56e-04 | 5 | 201 | 2 | EFO_0004510 | |
| Disease | level of coiled-coil domain-containing protein 134 in blood serum | 4.56e-04 | 5 | 201 | 2 | OBA_2044258 | |
| Disease | Varicella zoster virus seropositivity | 4.56e-04 | 5 | 201 | 2 | EFO_0009340 | |
| Disease | deoxycarnitine measurement | 6.80e-04 | 6 | 201 | 2 | EFO_0800259 | |
| Disease | antibody measurement, Epstein-Barr virus infection | 6.80e-04 | 6 | 201 | 2 | EFO_0000769, EFO_0004556 | |
| Disease | pneumocystosis (biomarker_via_orthology) | 6.80e-04 | 6 | 201 | 2 | DOID:11339 (biomarker_via_orthology) | |
| Disease | Treacher Collins syndrome (implicated_via_orthology) | 6.80e-04 | 6 | 201 | 2 | DOID:2908 (implicated_via_orthology) | |
| Disease | pemphigus | 6.80e-04 | 6 | 201 | 2 | EFO_1000749 | |
| Disease | Parkinson's disease (implicated_via_orthology) | 7.47e-04 | 157 | 201 | 6 | DOID:14330 (implicated_via_orthology) | |
| Disease | retinal vasculature measurement | DSCAML1 ACTL6B PLCL1 DNAH9 NPBWR1 ABHD2 FRY POLR3B CPNE4 HAS3 PDZD2 | 8.93e-04 | 517 | 201 | 11 | EFO_0010554 |
| Disease | antinuclear antibody measurement | 9.48e-04 | 7 | 201 | 2 | EFO_0005949 | |
| Disease | Anti-Helicobacter pylori IgG measurement | 9.48e-04 | 7 | 201 | 2 | EFO_0009352 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 9.48e-04 | 7 | 201 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | level of Phosphatidylcholine (16:0_22:6) in blood serum | 9.48e-04 | 7 | 201 | 2 | OBA_2045080 | |
| Disease | xanthurenate measurement | 9.99e-04 | 29 | 201 | 3 | EFO_0010551 | |
| Disease | pulmonary tuberculosis | 9.99e-04 | 29 | 201 | 3 | EFO_1000049 | |
| Disease | Intellectual Disability | ACTL6B MED23 PHIP CACNA1B CACNA1E RNASEH2A FRY POLR3B ASS1 ATIC | 1.05e-03 | 447 | 201 | 10 | C3714756 |
| Disease | brain aneurysm | 1.08e-03 | 113 | 201 | 5 | EFO_0003870 | |
| Disease | response to dolutegravir | 1.10e-03 | 30 | 201 | 3 | EFO_0600017 | |
| Disease | IgA glomerulonephritis (is_implicated_in) | 1.10e-03 | 30 | 201 | 3 | DOID:2986 (is_implicated_in) | |
| Disease | Drug habituation | 1.17e-03 | 115 | 201 | 5 | C0013170 | |
| Disease | Drug abuse | 1.17e-03 | 115 | 201 | 5 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.17e-03 | 115 | 201 | 5 | C4316881 | |
| Disease | Substance-Related Disorders | 1.17e-03 | 115 | 201 | 5 | C0236969 | |
| Disease | Drug Use Disorders | 1.17e-03 | 115 | 201 | 5 | C0013222 | |
| Disease | Drug Dependence | 1.17e-03 | 115 | 201 | 5 | C1510472 | |
| Disease | Substance Dependence | 1.17e-03 | 115 | 201 | 5 | C0038580 | |
| Disease | Substance Use Disorders | 1.17e-03 | 115 | 201 | 5 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.17e-03 | 115 | 201 | 5 | C0029231 | |
| Disease | Substance abuse problem | 1.21e-03 | 116 | 201 | 5 | C0740858 | |
| Disease | cutaneous mastocytosis | 1.22e-03 | 31 | 201 | 3 | EFO_1000886 | |
| Disease | IgG index | 1.26e-03 | 8 | 201 | 2 | EFO_0006929 | |
| Disease | aspergillosis (is_implicated_in) | 1.26e-03 | 8 | 201 | 2 | DOID:13564 (is_implicated_in) | |
| Disease | PAX-interacting protein 1 measurement | 1.26e-03 | 8 | 201 | 2 | EFO_0801868 | |
| Disease | 1-linoleoyl-2-arachidonoyl-GPC (18:2/20:4n6) measurement | 1.26e-03 | 8 | 201 | 2 | EFO_0800450 | |
| Disease | soluble CD163 measurement | 1.26e-03 | 8 | 201 | 2 | EFO_0020072 | |
| Disease | gdnf family receptor alpha-1 measurement | 1.26e-03 | 8 | 201 | 2 | EFO_0020400 | |
| Disease | asthma, seasonal allergic rhinitis | 1.34e-03 | 32 | 201 | 3 | EFO_0003956, MONDO_0004979 | |
| Disease | creatinine measurement | BRIP1 PSMD1 ATP9B RYR1 ACSM3 SLC35F3 MED23 OR5V1 DSCAM PHF7 SPATA20 SLC6A13 FRY MUSK HCRTR2 TDRD12 | 1.37e-03 | 995 | 201 | 16 | EFO_0004518 |
| Disease | sleep apnea measurement, obstructive sleep apnea | 1.46e-03 | 33 | 201 | 3 | EFO_0003918, EFO_0007817 | |
| Disease | asthma, Eczema, allergic rhinitis | 1.46e-03 | 121 | 201 | 5 | EFO_0005854, HP_0000964, MONDO_0004979 | |
| Disease | zinc fingers and homeoboxes protein 3 measurement | 1.61e-03 | 9 | 201 | 2 | EFO_0803299 | |
| Disease | Epstein Barr virus nuclear antigen 1 IgG measurement | 1.61e-03 | 9 | 201 | 2 | EFO_0007790 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TDPVNLCAAVLAKYL | 151 | P35503 | |
| LCAAVLAKYLSIPTV | 156 | P35503 | |
| KFLAVVFCLIGYVPS | 1101 | Q8WWZ7 | |
| ILEIKAFPFYNTVCI | 596 | Q13075 | |
| LHLTTFCLQYKPTVI | 181 | O60583 | |
| IFKLCSICLYLPQEQ | 196 | Q9GZU0 | |
| ACLNPVLYAFVSLKF | 281 | O00574 | |
| LVLVQFRPSEYSKAC | 676 | Q5SY80 | |
| VQSFKALPYVCLLIA | 1601 | Q15878 | |
| CQKSFLALVNLLSYP | 786 | Q96NH3 | |
| LLKLATCFEVASPEY | 851 | Q96Q42 | |
| YVITTSRCPQKAVIF | 51 | Q99616 | |
| LYVIVRCLNLKSPTA | 26 | P08910 | |
| YNIPAFFLCKTAVLT | 141 | O94805 | |
| KTQYEIACPIFAGLL | 916 | O94910 | |
| LLLVFLIYHQTCKVP | 136 | Q92685 | |
| YILAKLSTCQFALPL | 986 | Q7Z2Y8 | |
| PIYILVQLLSAFCAS | 101 | Q96PS8 | |
| STPFCLKLYQEILQL | 3286 | Q86UQ4 | |
| PCSLKIVNAVVSYIK | 391 | Q5VUY2 | |
| KYINTVVSCLVFVLG | 101 | P24530 | |
| SVSYFKCVQKEVLPS | 41 | P24385 | |
| VSQPNLKYTIKCVAL | 111 | Q8ND76 | |
| VSVIYSCVKLFPSPL | 806 | O95622 | |
| LNYLGTVSLTKCVLP | 161 | Q9Y394 | |
| TFVQSFKALPYVCLL | 1591 | Q00975 | |
| PNLRTTVKCVTLAIY | 136 | Q8N7R7 | |
| VRFELSCYSLAPQIK | 126 | P00966 | |
| YLKKFLSTPQAGCLV | 481 | Q8TE60 | |
| NCIKTSKYNILTFLP | 51 | P98198 | |
| VINYDLLCAVSKLGP | 166 | Q9UKA8 | |
| LLFQFIKSVLTVNPC | 401 | Q4ADV7 | |
| SYLCVSFLKTIFPSQ | 61 | Q9UND3 | |
| LIKAVPVNCTLYICD | 501 | Q8NAB2 | |
| LVPLQVLICSYKCFT | 321 | Q6ZNQ3 | |
| SFSGLIYLPNVKVLC | 1131 | Q6ZRR7 | |
| VTQLPYNIVKFCRAI | 251 | Q9NPB9 | |
| DLSFSCKYKVTVQPI | 491 | P23352 | |
| LCAIPFAKSYVTLAL | 386 | Q7RTY1 | |
| VKPYTLALAFKEQIC | 166 | P49914 | |
| TVLYKDTVVFRVAPC | 291 | Q6TGC4 | |
| ICSPLLYSVIISNKA | 126 | Q15617 | |
| ISNKACFSLILGVYI | 136 | Q15617 | |
| LLPLLKLSCSSIYVN | 181 | Q15617 | |
| SIYVNKLLILCVGAF | 191 | Q15617 | |
| ICSPLLYSIIISNKA | 161 | Q8NG78 | |
| ISNKACFSLILVVYV | 171 | Q8NG78 | |
| PFGTILCKIVISIDY | 136 | P35372 | |
| TLKLILIKFCYFQEP | 506 | O95256 | |
| LPFLKFINLSCNVIT | 936 | O60309 | |
| ILSCTFYAFKTRNVP | 751 | P41594 | |
| NIKYLAGSIFTCLTV | 336 | Q96AQ8 | |
| LPFLKFINLSCNVIT | 936 | A6NM11 | |
| LPFLKFINLSCNVIT | 936 | A6NMS7 | |
| VIFLLCFVPYNSTLA | 241 | Q9H1C0 | |
| NKFELNTYPLTVECL | 366 | Q8N0V5 | |
| IAYSLTKNIAELCPF | 791 | P54707 | |
| TKNIAELCPFLIYII | 796 | P54707 | |
| YFLVISCSQFVPALK | 161 | O43861 | |
| IPQSELILYLSACKF | 2141 | Q9Y3R5 | |
| VCGFIIKLQTSLYDP | 636 | O15327 | |
| TLYGPLLNAFLCIKE | 736 | Q2LD37 | |
| KAFCIIYSVIGIPFT | 131 | O00180 | |
| YLPNCITTLQESLIK | 196 | Q8NHP7 | |
| KSFVPLLDSKYVLCV | 666 | Q8WVS4 | |
| LVCSVTDFYPAQIKV | 146 | P05538 | |
| PFVIYAAKVFLRCIN | 451 | P17181 | |
| AVYCPVIAAVFIVLK | 61 | Q96RV3 | |
| IVLLLKAFPYCGSVV | 171 | Q9H341 | |
| VTCSILAYLPFKLEK | 386 | Q9Y5H3 | |
| AAICPASAKVLSLKY | 1621 | O15018 | |
| QAVLQLLPKTYILTC | 331 | Q6PIU2 | |
| CLLPAYFAVTEIRKL | 176 | Q9ULK4 | |
| PSVFTVCVSYLQKRL | 116 | O60662 | |
| SYLCVSFLKTIFPSQ | 61 | F8WFD2 | |
| FIDACYSSVNTPKLI | 66 | Q8NGP0 | |
| FTAVPLSIIVISYCL | 206 | O95371 | |
| LCTRDYKITQVLFPL | 16 | Q9H244 | |
| LLAKLADYVVPGCQT | 1476 | Q9Y4D8 | |
| YLCVSFLKTIFPSQN | 81 | E9PIF3 | |
| YLPLAVVVFCSLKVV | 181 | Q9HC97 | |
| SLTCQVFGYIISVLK | 111 | Q9Y2T5 | |
| FPLNCYVLLLSSKVI | 306 | Q9NYM4 | |
| YCLFQNEKLLPETVT | 126 | Q9HAS0 | |
| KQVFELLAALCIYSP | 141 | Q27J81 | |
| LYLVPFCKTAILLTV | 76 | Q5TF39 | |
| LAFVDICYTSAITPK | 66 | Q8NH89 | |
| YSSVTLPKLLVNLVC | 71 | Q9UGF7 | |
| IKFFPNVYALLKVLC | 671 | O43422 | |
| TVSQGILCFLPSYKL | 686 | Q9BX63 | |
| ICNPLRYSVILSKVL | 126 | Q9UGF6 | |
| LAFVDICYTSAITPK | 66 | Q8NH90 | |
| SLLEKYPCSKFIIAI | 61 | O95456 | |
| LCKVIPYLQTVSVSV | 126 | O43614 | |
| CYLPISILNVLKRVF | 316 | O43614 | |
| VSYFNIVLSILKICS | 216 | Q8NGP2 | |
| VNALTGFVLIPLACY | 391 | Q9ULW2 | |
| KIGVFSVLYTVPATC | 436 | Q9ULV1 | |
| LLVCSVTDFYPAQIK | 146 | P01920 | |
| CLEIVLKYLSRFPTN | 186 | Q7Z4Q2 | |
| QVIVDYLCKLSSLPA | 161 | Q7L8L6 | |
| ANKATLVCLISDFYP | 21 | P0CG04 | |
| PVLKLLVAAAKSQYC | 496 | Q16394 | |
| ALQKVVVPIYCTSFL | 236 | Q8IWX8 | |
| LFSKEQRAYITTLCP | 146 | Q8TDB6 | |
| YNKALELTEACPFVI | 491 | A8K855 | |
| VAVFKCLIPSSVQEY | 141 | Q8TD84 | |
| VFYVLSFCKSAVVPL | 321 | P35575 | |
| DFIQSYKILLLSCGI | 1966 | O75417 | |
| VIRTCINPVYSKLFT | 66 | Q96A23 | |
| ANKATLVCLISDFYP | 21 | P0DOY2 | |
| NRYSKLNCLVAPTLF | 311 | Q86WU2 | |
| AAALCIPEILYSQIK | 176 | P51686 | |
| GAVLYKACSVIFPLI | 551 | Q14534 | |
| ANKATLVCLISDFYP | 21 | P0DOY3 | |
| VKAIISCFPNVFIAS | 176 | O95395 | |
| ANKATLVCLISDFYP | 21 | P0CF74 | |
| VFLCYKKSVPASNAI | 191 | Q5VZ89 | |
| VVNSYLKSCFLIFPN | 1936 | Q9BZC7 | |
| LRKTYAPIFEVNLCL | 526 | Q0VDD8 | |
| LSAKTCSLFLPNYVQ | 1516 | Q76NI1 | |
| SAFKVYLTQQCIPFT | 71 | A6NN90 | |
| VQLVGIIKATYACFL | 416 | O00219 | |
| VLQLFCSSPKAALRY | 291 | Q9Y678 | |
| RANLTILFDKYLPTC | 2311 | Q9NYC9 | |
| LYPLVTCLLCVSQKQ | 361 | Q5TBA9 | |
| LILSDVYPFSCKAVA | 156 | Q9BRP7 | |
| IFLDANVKESYCPLV | 351 | Q92902 | |
| FVSLLETNKPYLVNC | 881 | Q14147 | |
| VLCYAASVNKKTIPS | 336 | Q9Y267 | |
| YFKNTTLLLVGVICV | 81 | Q9UKG4 | |
| IPLFDFVIYRLVSKC | 356 | Q16348 | |
| TNHCLYFLSTPAKVL | 3011 | P21817 | |
| AYFKVCSQSLLPIIN | 986 | Q6ZTR5 | |
| QIYKVLVLSRVVPYC | 1706 | Q6ZTR5 | |
| LFTLKCVYLPGIQNT | 2621 | Q8TDX9 | |
| INYSLCLKPDLLDFT | 61 | P55786 | |
| KSNIYPIVLFIRVCE | 1066 | Q9BXL7 | |
| LPNTNCFIKAIDVYL | 296 | O00591 | |
| LSLVFICFYIKKINP | 261 | P15260 | |
| TTCVYRENFKQLLLP | 16 | Q15077 | |
| YTLVLGFAIPVSTIC | 206 | P48145 | |
| TPLLNSIIYTLCNKE | 301 | Q8NH81 | |
| LSFADICYTTVIVPK | 66 | Q8NH93 | |
| SYLCVSFLKTIFPSQ | 61 | E9PJI5 | |
| SYLCVSFLKTIFPSQ | 61 | P0DM63 | |
| AYLCTITGFILPEKI | 276 | O75818 | |
| TLVNYEVPQFLDCLK | 711 | Q96J94 | |
| AVFKCIIPSSVEAYI | 141 | O60469 | |
| LIYPAICTNIESLNK | 321 | Q9BZD2 | |
| LPTIFCNIVLKTYVP | 811 | Q15147 | |
| IAIKDYCPTNFTTLK | 61 | Q9P0V3 | |
| LYPVVSAASICAKVA | 171 | O75792 | |
| NPSKFLIYTCLLLFS | 11 | Q9H7F4 | |
| QKCFLAQPVTLLDIY | 36 | Q13428 | |
| TFRIQLPCLSSYIKF | 376 | A0AVI2 | |
| KLTVFTVLCEQYQPS | 251 | Q7L5D6 | |
| CTLQFLAAPICLLYK | 301 | P09917 | |
| SYLCVSFLKTIFPSQ | 61 | E9PKD4 | |
| SVHYFCLILSSKLPQ | 56 | Q9BWX1 | |
| FCLICNYLSKIIPAL | 151 | P40937 | |
| LPVLTVLQTGACYKS | 471 | Q587J7 | |
| SYIKLGCLQFVFSIT | 951 | Q96QT6 | |
| LAYTPTCVIGLNKDL | 781 | Q99460 | |
| CQVPGIDYSLSKLAI | 1456 | Q9NT68 | |
| LAFVDLCYSSAITPK | 66 | Q8NH85 | |
| YRSFCKPQELLSLII | 631 | Q07889 | |
| CVPFFGIYLTNILKT | 926 | Q07889 | |
| LFVLCSESVPRFIKY | 396 | Q9NPQ8 | |
| LSFVDFCYSSIIVPK | 66 | Q8NGL0 | |
| ILFITCIPIILYFTK | 276 | Q8IY50 | |
| CIEKSYKSIFVLSPN | 686 | Q15399 | |
| ILQTLSKYPITVFCS | 311 | Q53FZ2 | |
| LAASSPYFCDQVLLK | 51 | O43298 | |
| CYQLPALLAKGITIV | 61 | O94762 | |
| CIKQVHYTLPASLSL | 271 | Q9H4B4 | |
| CTRPEVYFLLVQISK | 311 | Q15111 | |
| NKFAFVASEYPLILC | 476 | Q15111 | |
| YLVNPTCQVLVKDFT | 156 | Q7Z7L7 | |
| KGKITTVLQPCDLFY | 1616 | Q96RL7 | |
| VVFSLNYIPCKELIS | 451 | Q8IZQ1 | |
| SYRPLCVLTFKLNIF | 91 | Q8IUR5 | |
| IFFVPQDSIIVCSYK | 196 | Q68D42 | |
| LLHFIKDQTCYNIIP | 1256 | Q8WWQ0 | |
| EYLASLFPTCTVVKA | 131 | Q658P3 | |
| ENKILPFQYVLCAAT | 61 | Q12800 | |
| FATKTVIYLLNPCHL | 111 | Q5U3C3 | |
| VAILSFKLPYCQIAT | 706 | O75717 | |
| CVHSVYIPNKVLILA | 721 | Q8TB22 | |
| PAVCTATFLFSLIKY | 501 | Q9NSD5 | |
| FQLLYFPLICESKSV | 421 | Q9NPD5 | |
| ICAVALPFVASSYVI | 361 | O00624 | |
| VLQYALEFASSKPVC | 451 | Q9UHP3 | |
| LCAAVLAKYLSIPAV | 156 | P35504 | |
| CITFPTEYVKTQLQL | 41 | P53007 | |
| FVQSKLGYLTLILCT | 381 | Q687X5 | |
| QVCSLVLYPIKFIET | 126 | Q9BQJ4 | |
| KYITALQKFLLPSDC | 76 | Q70EL3 | |
| KPVITCFKSVLLIYT | 11 | O43657 | |
| VSSLRIPYACKLLFQ | 1101 | Q9NW08 | |
| LLDAVCLVPNKSLTY | 16 | Q5JUR7 | |
| IRVVACNLYPFVKTV | 96 | P31939 | |
| ICQLYISKPFIIDGF | 201 | Q8N841 | |
| CIEKSYKSIFVLSPN | 691 | Q9Y2C9 | |
| VLLVCKAVPATQIFF | 61 | Q6ZN44 | |
| SLQKFPILVVCYTNH | 646 | Q9P2E3 | |
| LLAQCVVYFARAPKS | 576 | Q96S55 | |
| YPDPIAQKTCFIILS | 836 | O43592 | |
| FSIYTLLGKQVTLCL | 1161 | Q7Z7G8 | |
| FKPQQLVSDICTIYL | 906 | Q14139 | |
| DCQYLFPAKVVSRLV | 506 | Q13769 | |
| VTQFVYTASIPALLC | 521 | Q9H9Y6 | |
| SILCIPFAKNIYGLI | 371 | Q05940 | |
| FNQSLYLVSCLKLLP | 626 | Q6ZQQ6 | |
| NRVIFFYLSCVPKTQ | 1841 | O60293 | |
| AYCFATLTSLPQILV | 1646 | P15822 | |
| KCVNVFTQKPLLSIY | 306 | P51508 | |
| YIPFLQLNCDLRKTS | 201 | Q9GZU3 | |
| FTSLPVYAIIVANFC | 311 | Q8NDX2 | |
| KCYLHTNVALVAPLL | 466 | Q96JC1 | |
| LCGAVLAKYLSIPAV | 156 | P22310 | |
| QLFITKPGLYTCIAT | 271 | O15146 |